Skip to content

The vertebra augmentation combined with intraoperative radiotherapy for spine metastasis: A randomized controlled single center clinical trial

The vertebra augmentation combined with intraoperative radiotherapy for spine metastasis: A randomized controlled single center clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-15007670
Enrollment
Unknown
Registered
2015-12-21
Start date
2016-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spine metastasis

Interventions

A:Vertebra augmentation combined with intraoperative radiotherapy
B:External beam radiotherapy

Sponsors

Sun Yat-sen memorial hospital, Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Age between 18 and 65; 2. Pathological or imaging proved spine metastasis; 3. Involved T3-T12 or L1-L5 vertebrae; 4. Predicted Survival longer than 3 months; 5. Documented consent.

Exclusion criteria

Exclusion criteria: 1. Not tolerated with general anesthesia/surgery; 2. Coagulation disorders; 3. Not tolerated with MRI/CT scan during follow-up; 4. Malignant epidural spinal cord compression; 5. Severe spinal instability; 6. Pregnant/breast-feeding women; 7. Hypersensitive to bone cement; 8. Previous external radiotherapy; 9. Puncture failure; 10. Complicated with psychological disorders that not able to provide informed consent; 11. Complicated with severe diseases that shorten survival or cause chronic pain; 12. Dyscrasia or multi-organ dysfunction; 13. Multi primary tumors; 14. Drug abuse or other medical, psychological or social conditions affect participation or assessing of our trial; 15. Hypersensitive to given drugs in our trial; 16. Any conditions affecting the safety or participation.

Design outcomes

Primary

MeasureTime frame
1-year tumor progression-free survival;

Secondary

MeasureTime frame
Pain release rate;spinal stability;neurological function;ambulation;complication rate;economical indexes;6-month survival;1-year survival;

Countries

China

Contacts

Public ContactHUANG Lin
13719252070@139.com+86 13719252070

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026